Model Number FHC-A102-OBC554 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 09/22/2015 |
Event Type
malfunction
|
Manufacturer Narrative
|
Investigation conclusion: customer's observation was not replicated in-house with retention devices.Retention devices were tested with 20 miu/ml hcg urine control and 3 high level of hcg urine controls (201.8 iu/ml, 203.4 iu/ml and 205.2 iu/ml); all results were hcg positive at read time.No false negatives were obtained.Manufacturing batch record review did not uncover any abnormalities.Root cause could not be determined without patient specimen in-house analysis and insufficient information provided.Based on the information available, there is no indication of a product deficiency.No corrective action is required at this time.
|
|
Event Description
|
Report of fn urine hcg on (b)(6) 2015.(b)(6) 2015 qualitative serum = positive.Patient reported "spotting." (b)(6) 2015 ultrasound showed no visible intrauterine gestational sac.(b)(6) 2015 beta quant was 5 miu/ml.(b)(6) 2015 beta quant was <1 miu/ml.Customer cannot state if pregnancy was terminated or if patient miscarried.Date unknown.Patient was administered depo-provera because the rapid assay resulted negative at the designated read time of 3-5 minutes; however, the operator noticed a faint test line after 10 minutes (and ran it twice).Thus, next day bloodwork was done and the beta quant was positive (awaiting concentration).The serum was tested twice - on (b)(6) 2015 blood was drawn and sent out to labcorp and a qualitative assay was run and the result was positive (brand unknown).A quant was done (b)(6) 2015 and was 5 miu/ml.A second quant was run on (b)(6) 2015 and resulted as <1 miu/ml (instrument unknown).No specific patient information provided.No additional details reported.
|
|
Search Alerts/Recalls
|